92
Participants
Start Date
December 14, 2021
Primary Completion Date
October 8, 2024
Study Completion Date
October 8, 2024
Magrolimab
Administered intravenously
Nab-Paclitaxel
Administered intravenously
Paclitaxel
Administered intravenously
Sacituzumab Govitecan-hziy
Administered intravenously
Chang Gung Memorial Hospital, Linkou, Guishan District
St Vincent's Hospital Melbourne, Fitzroy
Box Hill Hospital, Box Hill
Peninsula Health, Frankston
Ballarat Oncology & Haematology Services, Wendouree
Princess Alexandra Hospital, Woolloongabba
University of the Sunshine Coast, Sippy Downs
Cairns and Hinterland Hospital and Health Service, Cairns
Cancer Research SA, Adelaide
Flinders Medical Centre, Bedford Park
Asan Medical Center, Seoul
NYU Investigational Pharmacy, Laura & Isaac Perlmutter Cancer Center, New York
National Cancer Center, Goyang-si
Taipei Veterans General Hospital, Beitou District
Stony Brook University, Stony Brook
Charleston Oncology, Charleston
Southeastern Regional Medical Center, LLC, Newnan
Winship Cancer Institute Emory University, Atlanta
University Cancer & Blood Center,LLC, Athens
Mayo Clinic, Jacksonville
Changhua Christian Hospital, Changhua
Allina Health Cancer Institute, Minneapolis
Mayo Clinic, Rochester
Orchard Healthcare Research Inc, Skokie
Ochsner Clinic Foundation, New Orleans
Kaohsiung Medical University Chung-Ho Memorial Hospital, Sanmin District
Huntsman Cancer Institute, University of Utah, Salt Lake City
Mayo Clinic, Phoenix
Saint John's Cancer Institute, Santa Monica
Providence Medical Foundation, Fullerton
Women's Cancer Care, Fresno
University of California San Francisco, San Francisco
Providence Medical Foundation, Santa Rosa
Astera Cancer Care, East Brunswick
Barwon Health- University Hospital Geelong, Geelong
Queen Mary Hospital, Hong Kong
Princess Margaret Hospital, Kowloon
Prince of Wales Hospital, New Territories
National Taiwan University Hospital, Tapiei
Samsung Medical Center, Gangnam-Gu
Seoul National University Hospital, Jongrogu
Severance Hospital Yonsei University Health System, Seoul
University Hospitals of Leicester NHS Trust, Leicester
University College London, London
The Christie NHS Foundation Trust, Manchester
Lead Sponsor
Gilead Sciences
INDUSTRY